Sumatriptan
سوماتریپتان
🧠 Nervous SystemTriptan
Market / country: 🇺🇸 USA
Imitrex (US)
🧮 Dose calculator
Acute migraine attack · Regimen source: FDA Sumatriptan · 2.1
- • 50 and 100 mg may be more effective than 25, but 100 not necessarily better than 50. Second dose at least 2 h later; max 200 mg/24 h. FDA Sumatriptan · 2.1
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Ischemic coronary disease, coronary vasospasm, stroke or TIA, peripheral vascular disease, uncontrolled hypertension; other triptans or ergots within 24 h. FDA Sumatriptan · 4
Formulations
- 25 mg tablet — tablet 🇺🇸 USA FDA Sumatriptan · 3
- 50 mg tablet — tablet 🇺🇸 USA FDA Sumatriptan · 3
- 100 mg tablet — tablet 🇺🇸 USA FDA Sumatriptan · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Sumatriptan · 8.1
“Risk Summary Data from a prospective pregnancy exposure registry and epidemiological studies of pregnant women have not detected an increased frequency of birth defects or a consistent pattern of birth defects among women exposed to sumatriptan compared with the general population (see Data) .”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Sumatriptan · 8.2
“Risk Summary Sumatriptan is excreted in human milk following subcutaneous administration (see Data) .”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Sumatriptan · 8.4
“Safety and effectiveness in pediatric patients have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Sumatriptan · 8.5
“In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function and of concomitant disease or other drug therapy.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA219036
- DailyMed (FDA label)FDA Sumatriptan
- MedlinePlus (NIH)SumatriptanSumatriptan Injection
- WHO ATC/DDDN02CC01
- Darooyab (Iran)Sumatriptan
🇮🇷 Registered in Iran Darooyab · G-864/Sumatriptan
Dosage forms with Iranian generic codes, per Darooyab.
- 53224 · SUMATRIPTAN 20MG 60 dose NASAL SPRAY · اسپری بینی سوماتریپتان ۲۰ میلیگرم ۶۰ دوز
- 10783 · SUMATRIPTAN 12MG/1ML 0.5ML AMP · آمپول سوماتریپتان ۱۲ میلیگرم / ۱ میلیلیتر ۰٫۵ میلیلیتر
- 04963 · SUMATRIPTAN 6MG/1ML AMP · آمپول سوماتریپتان ۶ میلیگرم / ۱ میلیلیتر
- 02005 · SUMATRIPTAN SUCCINATE 100MG FC TAB · قرص روکشدار سوماتریپتان سوکسینات ۱۰۰ میلیگرم
- 02004 · SUMATRIPTAN SUCCINATE 50MG FC TAB · قرص روکشدار سوماتریپتان سوکسینات ۵۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Sumatriptan · 3FDA Sumatriptan · 2.1FDA Sumatriptan · 8.4FDA Sumatriptan · 4FDA Sumatriptan · 8.1FDA Sumatriptan · 8.2FDA Sumatriptan · 8.5FDA Sumatriptan · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-864/Sumatriptan
- Clinical review⚠ Unverified